
Urologist Henry Rosevear, MD, reviews his personal highlights from AUA 2017, along with a few bumps in the road.

Urologist Henry Rosevear, MD, reviews his personal highlights from AUA 2017, along with a few bumps in the road.

"Learning from my junior residents means realizing that sometimes, maybe even oftentimes, they may know more than I do," writes Amy Pearlman, MD.

Urology resident Nirmish Singla, MD, discusses the insight he’s gained from the experiences and perspectives of visiting professors and residents.

After reading an article suggesting that surgeons are similar to athletes, Henry Rosevear, MD, argues that surgeons should start treating themselves as such and also be aware of the impact poor sleep habits can have on performance.

While no resource is perfect, it is worthwhile to familiarize yourself with some contemporary methodology and predictive tools to help determine life expectancy in localized prostate cancer patients.

Urologist Henry Rosevear, MD, thinks it may be time to bring patients into the prior authorization process.

In preparation for the AUA annual meeting in May, urologist Henry Rosevear, MD, shares the 10 sessions he’s looking forward to the most.

In many ways, policymakers, insurance companies, and certain health care providers seem to have a total disregard for men’s health, writes Henry Rosevear, MD.

While questions about experience can be uncomfortable for new surgeons, Nirmish Singla, MD, believes the process of mastering procedures is invaluable to conveying the confidence necessary to help patients feel comfortable.

Urologic oncology fellow, Ariel Schulman, MD, shares some tips to help residents make research a positive experience.

State policy makers are working to ensure that NPs and physicians will collaborate within the health care team as they look to modernize NP licensure framework.

Henry Rosevear, MD, examines how the political notion of a “post-truth” world has seeped into medicine.

Dr. Henry Rosevear apologizes to those he may have hurt with his prescription habits for pain control and discusses the steps he is taking to help remedy the narcotics epidemic.

Urology resident, Nirmish Singla, MD, goes over some of the ways urologists can stay educated and informed in the infinite and dynamic curriculum that defines the medical field.


Henry Rosevear, MD, discusses the ten things he’d like to see happen in 2017 for the field of urology.

UT blogger Lisa Kerr, PA-C, makes her case for using physician assistants to first assist on surgical procedures.

Urologist Henry Rosevear, MD, discusses a recent OR experience that had him rethink his value as a surgeon and consider a possible alternative to better align the financial incentives of the surgeon with the hospital's goals.

Urology resident, Amy Pearlman, MD, discusses how the experience of helping her mother go through radiation therapy changed how she is able to relate to her patients.

Urologist Henry Rosevear, MD, discusses actor Ben Stiller's recent blog post that credits PSA tests for saving his life after he was diagnosed with prostate cancer and the urologic community's surprising reaction to the article.

In his recent blog post “My $4.07 check: A sign of the times,” Henry Rosevear, MD, shared how, after managing a patient with an obstructing stone and billing $1,332.25 for his services, he received a check from the Colorado Indigent Care Program, the patient’s insurer, for $4.07. His blog post prompted a wave of comments, commiseration, and suggestions.

"This is the step whereby practices can apply good, evidence-based, pathway-driven medicine to not only provide excellent outcomes for patients, but also be financially successful in the process," writes Henry Rosevear, MD.

In conjunction with Urology Times' recent coverage of maintenance of certification (MOC), we asked several members of the UT Editorial Advisory Board to weigh in with their thoughts on MOC.

Jamin Brahmbhatt, MD, discusses his favorite tools to efficiently maintain an active online presence.

Urologist Henry Rosevear, MD discusses his thoughts on PSA screening and the recent increase in patients presenting with metastatic disease.